A selection of recent presentations and posters presented by the London Sarcoma Service team can be found below:

​​​

  • National BSG 2026 (Presentation) - Evaluating the accuracy of custom 3D-printed jigs in bone tumour resections: a single centre study 
  • National BSG 2026 (Presentation) - Updated outcomes of moderately hypofractionated definitive radiotherapy (MHDRT) using a simultaneous integrated boost for inoperable non-extremity sarcomas 
  • National BSG 2026 (Presentation) - Oral Vinorelbine Monotherapy in Patients with Desmoid Tumours – the UCLH Experience 
  • National BSG 2026 (Presentation) - Gait and Physical Activity in Patients with Proximal Tibial Replacelemnts after Musculoskeletal Tumours – A Multidimensional Functional Outcome Assessment using the Stanmore OutceMes Project (STOMP) 
  • National BSG 2026 (Presentation) - Long-Term Efficacy and Safety of Vimseltinib in Patients with Tenosynovial Giant Cell Tumour (TGCT): Results From the MOTION Phase 3 Trial 
  • National BSG 2026 (Presentation) - UCLH Experience of Fertility Preservation in Adult Female Sarcoma Patients Receiving Systemic Therapy
  • National BSG 2026 (Poster) - A Service Evaluation of Post Operative Inpatient Therapy Treatment for Hip Disarticulation and Transpelvic Amputations 
  • National BSG 2026 (Poster) - RISE: Recover, Inspire, Strengthen, Engage Exercise Group 
  • National BSG 2026 (Poster) - Implementation of a new diagnostic model for adult soft tissue sarcoma across London East of England and the South East region 
  • National BSG 2026 (Poster) - Indeterminate Pulmonary Nodules in Osteosarcoma: Imaging Burden and Outcomes from the ICONIC Trial – George Seligmann, UCLH
  • National BSG 2026 (Poster) - Pimicotinib in Tenosynovial Giant Cell Tumour (TGCT): Extended Efficacy, Safety and Patient-Reported Outcomes from the Phase 3 MANEUVER Study 
  • National BSG 2026 (Poster) - Chordoma Incidence, survival and management in England2013-2022; An analysis from the National Disease Registration Service (NDRS)
  • International CTOS 2023 (Presentation) WHAT ARE THE EXPERIENCES OF GAIT, ACTIVITY LEVELS AND PHYSICAL FUNCTIONING IN PROXIMAL FEMORAL REPLACEMENT AFTER MUSCULOSKELETAL TUMORS?
  • International CTOS 2023 (Presentation) REAL-WORLD MONITORING OF PHYSICAL ACTIVITY USING AN ACCELEROMETER AFTER LOWER LIMB SURGERY FOR A SARCOMA.
  • International CTOS 2023 (Presentation) EXPERIENCE OF PHYSICAL DISABILITIES AND CANCER-RELATED QUALITY OF LIFE AFTER SPINAL TUMORS- STUDY OF A NATIONAL SURVEY IN ENGLAND.
  • International CTOS 2023 (Presentation) BALANCE, GAIT AND BIOMECHANICAL COMPENSATIONS DURING DIFFERENT SPEEDS OF WALKING AFTER TREATMENT FOR DISTAL FEMORAL MUSCULOSKELETAL TUMOURS AND ASSOCIATED LIMITATIONS ON RETURN TO NORMAL LIVING
  • International CTOS 2023 (Presentation) WHAT IS THE EXPERIENCE OF THOSE WITH CANCER-RELATED REDUCED QUALITY OF LIFE AND ASSOCIATED PHYSICAL DISABILITIES AFTER UPPER LIMB SARCOMA TREATMENT IN ENGLAND? A NATIONAL STUDY OF OUTCOMES.
  • International CTOS 2023 (Presentation) WHAT ARE THE EXPERIENCES OF BALANCE, GAIT AND NEURO-MUSCULAR CONTROL OUTCOMES AFTER PROXIMAL FEMORAL REPLACEMENTS FOR MUSCULOSKELETAL TUMOURS?
  • International CTOS 2023 (Presentation) UNDERSTANDING THE EXPERIENCES OF PATIENTS RETURNING TO ACTIVITIES OF DAILY LIVING AND EXERCISE FOLLOWING LIMB SPARING SURGERY FOR BONE OR SOFT TISSUE SARCOMA AROUND THE KNEE.
  • International CTOS 2023 (Presentation) GAIT KINEMATICS OF SARCOMA PATIENTS AT 1 YEAR POST-OPERATIVE INTERNAL HEMIPELVECTOMY SURGERY: A RETROSPECTIVE STUDY
  • International CTOS 2023 (Presentation) BALANCE AND GAIT OUTCOMES AFTER 1-YEAR POST-OPERATIVE HEMIPELVECTOMY SURGERY
  • International CTOS 2023 (Poster) THE EVALUATION AND OUTCOMES OF MESENTERIC AND INTRA-ABDOMINAL DESMOIDS: A TARPSWG STUDY
  • International CTOS 2023 (Poster) Dosimetric Characteristics, Outcomes and Prognostic Factors of patients with Extracranial chordomas and chondrosarcomas treated with High Dose Radiotherapy: A Large Single Institution Cohort
  • International CTOS 2023 (Presentation)-  THE CELL ATLAS OF CLEAR CELL SARCOMA
  • International CTOS 2023 (Presentation) - THE GENOMIC LANDSCAPE OF CLEAR CELL SARCOMA
  • International CTOS 2023 (Poster) - EPIGENETIC AGE ACCELERATION IS A DISTINCTIVE TRAIT OF EPITHELIOID SARCOMA WITH POTENTIAL THERAPEUTIC IMPLICATIONS

  • International CTOS 2023 (Poster) - Dimosthenis A, et al Controversies in the management of patients with soft tissue sarcoma: results and recommendations from the first Conference on State of Science in Sarcoma (CSSS) Connective Tissue Oncology Society, 2023 Annual Meeting Poster.

  • International CTOS 2023 (Poster) - Wild T et al. The evaluation and outcomes of mesenteric and intra-abdominal desmoids: a TARPSWG Study. Connective Tissue Oncology Society, 2023 Annual Meeting Poster.

  • International CTOS 2023 (Poster) - Palmerini E et al. Ultra-rare Undifferentiated Small Round Cell Sarcoma: how should we treat them? An analysis from the GRACEFUL project. Connective Tissue Oncology Society, 2023 Annual Meeting Poster.

  • National BSG 2022 (Poster) - Personalised Cancer Care. Introducing Holistic Needs Assessment into a Sarcoma Service - Patient and Clinician Experience
  • National BSG 2022 (Poster) - What is the Burden of Long-term Physical Limitations after Surgery for Extremity Sarcoma?
  • National BSG 2022 (Poster) - Developing Rehabilitation Guidelines following Proximal Femoral Replacement Surgery
  • National BSG 2022 (Poster) - Identifying barriers in the Paediatric Bone Sarcoma Rehabilitation pathway in South East England
  • National BSG 2022 (Poster) - Stanmore Children's Orthopaedic Outcome Project (SCOOP): Preliminary Findings of Children and Young Adults' Experience after Orthopaedic Surgery
  • National BSG 2022 (Poster) - The Role of Post-operative Radiotherapy in Osteosarcoma: A Retrospective Analysis from the London Sarcoma Service (LSS)
  • National BSG 2022 (Poster) - Role of adjuvant pelvic radiotherapy in localised leiomyosarcomas and undifferentiated endometrial sarcomas
  • National BSG 2022 (Presentation) - A review of psychosocial needs of patients in the Sarcoma Patient Pathway using the electronic Holistic Needs Assessment (eHNA)